In our previous studies we explored the potential of using a combined US/magnetic resonance (MR) multimodality contrast agent, albumin-gadolinium-diethylenetriaminepentacetate (Gd-DTPA) MBs, to induce BBB opening and for distinguishing between FUS-induced BBB opening and intracerebral hemorrhage in MR T1-weighted contrast imaging. According to the previous study in the literature, 1-2 µm bubbles have more pronounced acoustic activity at frequencies above 10 MHz. The present study developed a new targeted US/MR multimodality MB and the acoustic properties were compared with two commercial MBs, SonoVue and Targestar SA. The acoustic activities of these 1.15-2.78 µm MBs with different shells at 10 MHz were investigated. The feasibility of designing a new targeted US/MR multimodality MB was investigated. The lifetime (survival of MBs in the liquid suspension) and attenuation properties of lipid MBs (SonoVue and Targestar SA), albumin-(Gd-DTPA) MBs, and avidin-conjugated albumin (avidin-albumin)-(Gd-DTPA) MBs at 10 MHz were investigated with the pulse-echo substitution method. It was found that incorporating avidin into the albumin MBs and avidin-albumin-(Gd-DTPA) MBs affects the size distribution but does not affect the concentration of MBs produced. The avidin-albumin-shelled MBs had more significant nonlinear activity at 4-18 MHz (p=0.025), while the nonlinear activity of the other MBs peaked at 6-24 MHz (p=0.003-0.044). Moreover, the incorporation of paramagnetic metal ions into the MB shells increased their attenuation coefficients. With regard to the lifetime of these agents, the attenuations of the SonoVue and Targestar SA lipid MBs were 87.96% and 8.74%, respectively, while those of albumin MBs, avidin-albumin MBs, albumin-(Gd-DTPA) MBs, and avidin-albumin-(Gd-DTPA) MBs were 49.52%, 41.38%, 74.69%, and 100%, respectively. Avidin conjugation decreased the lifetime of the albumin MBs, but not that of the lipid MBs. The incorporation of paramagnetic metal ions into the shells of albumin MBs did not decrease the lifetime.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/EMBC.2013.6611160 | DOI Listing |
Materials (Basel)
December 2024
Latvian State Institute of Wood Chemistry, Dzerbenes iela 27, LV 1006 Riga, Latvia.
In this study, different combinations of mycelium biocomposites (MBs) were developed using primary substrates sourced from the local agricultural, wood processing, and paper industries. The physicomechanical properties, thermal conductivity, and fire behavior were evaluated. The highest bending strength was achieved in composites containing waste fibers and birch sanding dust, with a strength competitive with that of synthetic polymers like EPS and XPS, as well as some commercial building materials.
View Article and Find Full Text PDFInsects
December 2024
Shandong Institute of Sericulture, Shandong Academy of Agricultural Sciences, Yantai 265500, China.
Intestinal microbes are known to impact the growth and development of insects. However, there are few reports on the intestinal microbiota of silkworms (). The present study used Illumina 16S rRNA gene sequencing to investigate the changes over time in the intestinal bacteriome of fifth-instar silkworms fed mulberry leaf (MB) or artificial diet (AD).
View Article and Find Full Text PDFInt J Mol Sci
December 2024
Department of Pharmacology & Toxicology, Cancer Center & Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Oncolytic virotherapy has shown great promise in mediating targeted tumor destruction through tumor-selective replication and induction of anti-tumor immunity; however, obstacles remain for virus candidates to reach the clinic. These include avoiding neutralizing antibodies, preventing stimulation of the adaptive immune response during intravenous administration, and inducing sufficient apoptosis and immune activation so that the body's defense can work to eradicate systemic disease. We have developed a co-formulation of oncolytic viruses (OVs) with Imagent lipid-encapsulated, perfluorocarbon microbubbles (MBs) to protect the OVs from the innate and adaptive immune system.
View Article and Find Full Text PDFMedicina (Kaunas)
December 2024
Division of General Surgery, Tel Aviv Sourasky Medical Center, Tel-Aviv 6423906, Israel.
: Religious fasting in patients after Metabolic and Bariatric Surgery (MBS) remains a topic with limited clarity. This study aims to present the results of a survey on religious fasting in patients after MBS in Israel. The questionnaire was sent to members of the Israeli Society for Metabolic and Bariatric Surgery (ISMBS).
View Article and Find Full Text PDFBrain Sci
November 2024
Headache Outpatient Clinic, Neurology Department, Patras Agios Andreas General Hospital of Patras, 26335 Patras, Greece.
The present open-label multicenter pilot study sought to prospectively evaluate the efficacy and safety of rimegepant in treating migraine attacks. The primary endpoint was pain freedom at two hours post-dose, while the co-primary efficacy endpoints included a reduction in the headache intensity and freedom from the most bothersome symptoms (MBS) associated with migraine at the same time point. To test the potential efficacy of rimegepant, patients were asked to record in a questionnaire all the relevant changes with each migraine attack treated with rimegepant at two hours post-dose vs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!